Brodka-Pfeiffer Katharina, Häusler Heribert, Grass Peter, Langguth Peter
Institute of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany.
Drug Dev Ind Pharm. 2003 Nov;29(10):1077-84. doi: 10.1081/ddc-120025865.
Micronization is a high-energy process that induces changes in the crystallinity of materials. As a result, the crystalline structures on the particles' surface are being destroyed and amorphous areas are formed. After micronization of salbutamol sulfate to be used in dry powder inhalers, only small amounts of amorphous material are produced. Nevertheless, even these small amounts can have important effects on the physical stability of the powder. The amorphous state is thermodynamically unstable and tends to convert to the stable, crystalline state. The recrystallization process of disordered regions on the particles' surface leads to particle growth of milled particles. In this case, bridges of solid material are being formed between the individual particles, which leads to particle growth. This is an undesirable process, because particles for pulmonary administration are designed to range between 1 and 10 microm in diameter to exert respirative effect. In the present investigation, salbutamol sulfate is micronized by an air jet mill, and the generated products are exposed to different conditions. Thereafter, the best possible conditioning parameters and storage conditions for the micronized salbutamol sulfate are worked out and rated. The aim of this treatise is to demonstrate the importance of conditioning following micronization.
微粉化是一个高能过程,会引起材料结晶度的变化。结果,颗粒表面的晶体结构被破坏,形成无定形区域。将用于干粉吸入器的硫酸沙丁胺醇微粉化后,仅产生少量无定形物质。然而,即使是这些少量的无定形物质也会对粉末的物理稳定性产生重要影响。无定形状态在热力学上是不稳定的,倾向于转变为稳定的结晶状态。颗粒表面无序区域的重结晶过程导致研磨颗粒的颗粒生长。在这种情况下,单个颗粒之间形成固体材料桥,导致颗粒生长。这是一个不良过程,因为用于肺部给药的颗粒设计直径在1至10微米之间以发挥呼吸作用。在本研究中,通过气流粉碎机对硫酸沙丁胺醇进行微粉化,并将生成的产物暴露于不同条件下。此后,确定并评估微粉化硫酸沙丁胺醇的最佳调节参数和储存条件。本论文的目的是证明微粉化后调节的重要性。